Circulating endothelial cells and their apoptotic fraction are mutually independent predictive biomarkers in Bevacizumab-based treatment for advanced colorectal cancer

被引：0
|
作者：
Mariangela Manzoni
Sara Mariucci
Sara Delfanti
Bianca Rovati
Monica Ronzoni
Fotios Loupakis
Silvia Brugnatelli
Carmine Tinelli
Eugenio Villa
Alfredo Falcone
Marco Danova
机构：
[1] Fondazione IRCCS Policlinico S. Matteo,S.C. Oncologia
[2] Istituto Scientifico S. Raffaele,Oncologia Medica
[3] Oncologia 2 Universitaria,Dipartimento di Oncologia, dei Trapianti e delle Nuove Tecnologie in Medicina
[4] Azienda Ospedaliero-Universitaria Pisana,Unità di Epidemiologia Clinica e Biometria
[5] Fondazione IRCCS Policlinico S. Matteo,undefined
来源：
Journal of Cancer Research and Clinical Oncology | 2012年 / 138卷
关键词：
Biomarkers; Circulating endothelial cells; Apoptosis; Angiogenesis; Colorectal cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1187 / 1196
页数：9
相关论文
共 50 条
  • [21] Predictive value of baseline CD66e/CEA serum levels on efficacy of bevacizumab-based treatment in advanced colorectal cancer
    Prager, Gerald W.
    Bramswig, Kira H.
    Zielinski, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [22] BIOLOGICAL MARKERS OF ANGIOGENESIS: APOPTOTIC CIRCULATING ENDOTHELIAL CELLS IN COLORECTAL CANCER PATIENTS TREATED WITH BEVACIZUMAB (BEV)-BASED COMBINATION THERAPY
    Mariucci, S.
    Bencardino, K.
    Rovati, B.
    Manzoni, M.
    Ronzoni, M.
    Chatzileontiadou, S.
    Delfanti, S.
    Villa, E.
    Danova, M.
    ANNALS OF ONCOLOGY, 2008, 19 : 137 - 137
  • [23] Dicer and Drosha expression and response to Bevacizumab-based therapy in advanced colorectal cancer patients
    Vincenzi, Bruno
    Zoccoli, Alice
    Schiavon, Gaia
    Iuliani, Michele
    Pantano, Francesco
    Dell'Aquila, Emanuela
    Ratta, Raffaele
    Muda, Andrea Onetti
    Perrone, Giuseppe
    Brunelli, Chiara
    Correale, Pierpaolo
    Riva, Elisabetta
    Russo, Antonio
    Loupakis, Fotios
    Falcone, Alfredo
    Santini, Daniele
    Tonini, Giuseppe
    EUROPEAN JOURNAL OF CANCER, 2013, 49 (06) : 1501 - 1508
  • [24] Bevacizumab-based conformal radio-chemotherapy for locally advanced inoperable colorectal cancer
    Koukourakis, M. I.
    Tsoutsou, P. G.
    Pitiakoudis, M.
    Kouklakis, G.
    Liratzopoulos, N.
    Polychronidis, A.
    Abatzoglou, I.
    Simopoulos, C.
    Manolas, K.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [25] DICER AND DROSHA EXPRESSION AND RESPONSE TO BEVACIZUMAB-BASED THERAPY IN ADVANCED COLORECTAL CANCER PATIENTS
    Zoccoli, A.
    Iuliani, M.
    Pantano, F.
    Schiavon, G.
    Ratta, R.
    Correale, P.
    Muda, A. Onetti
    Santini, D.
    Tonini, G.
    Vincenzi, B.
    ANNALS OF ONCOLOGY, 2012, 23 : 530 - 530
  • [26] Bevacizumab-Based Therapies in the First-Line Treatment of Metastatic Colorectal Cancer
    Strickler, John H.
    Hurwitz, Herbert I.
    ONCOLOGIST, 2012, 17 (04): : 513 - 524
  • [27] Predictive Value of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer Patients Treated by Bevacizumab-Based Therapy.
    Mego, M.
    De Giorgi, U.
    Hsu, L.
    Dawood, S.
    Andreoupolou, E.
    Valero, V.
    Handy, B. C.
    Ueno, N. T.
    Reuben, J. M.
    Cristofanilli, M.
    CANCER RESEARCH, 2009, 69 (24) : 650S - 650S
  • [28] Predictive value of circulating tumor cells positive for VEGFR expression in patients with advanced colorectal cancer undergoing treatment with FOLFOX plus bevacizumab
    Jose Serrano, M.
    Gabriel Ortega, Francisco
    Antonio Lorente, Jose
    Delgado, Mayte
    Luis Puche, Jose
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [29] Efficacy and safety of bevacizumab-based combination therapy for treatment of patients with metastatic colorectal cancer
    Xu, Ran
    Xu, Chen
    Liu, Chuntong
    Cui, Can
    Zhu, Jing
    ONCOTARGETS AND THERAPY, 2018, 11 : 8605 - 8621
  • [30] PREDICTIVE POTENTIAL OF CIRCULATING ENDOTHELIAL CELLS IN METASTATIC COLORECTAL CANCER (MCRC) PATIENTS RECEIVING BEVACIZUMAB CONTAINING CHEMOTHERAPY (JAPAN)
    Matsusaka, S.
    Mizunuma, N.
    Suenaga, M.
    Shinozaki, E.
    Mishima, Y.
    Terui, Y.
    Hatake, K.
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I10 - I10
12345